300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
LATAM
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
New Zealand
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Seychelles
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Switzerland (November 2026)

The most active venture capital funds and angel investors investing in Switzerland Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Switzerland Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Foundation for Innovation and Technology (FIT)
VC Fund
13 Switzerland, France, United States Debt Financing, Grant, Seed Health Care, Information Technology, Artificial Intelligence $20k–$2.5M
Zürcher Kantonal Bank
VC Fund
9 Switzerland, Germany, Japan Seed, Series A, Series B Health Care, Biotechnology, Medical Device $1M–$20M
Verve Ventures
VC Fund
5 Switzerland, Germany, France Series A, Seed, Series B Software, Health Care, Biotechnology $1.3M–$45M
EQT Life Sciences
VC Fund
4 United States, Switzerland, The Netherlands Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
Lakestar
VC Fund
4 United Kingdom, Germany, United States Seed, Series A, Series B Software, Artificial Intelligence, Financial Services $2.2M–$91M
Eclosion SA
VC Fund
4 Switzerland Seed, Series C Biotechnology, Pharmaceutical, Health Care $1.6M–$28M
M Ventures
VC Fund
4 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Versant Ventures
VC Fund
4 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $4.7M–$107M
White Loop Capital
VC Fund
3 France, Canada, Switzerland Seed, Series A, Pre-Seed Software, Blockchain, Cryptocurrency $1M–$27M
Kinled Holding
VC Fund
3 United Kingdom, United States, Switzerland Seed, Series A, Venture - Series Unknown Health Care, Biotechnology, Software $594k–$40M
Pfizer Venture Investments
VC Fund
3 United States, United Kingdom, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $12M–$120M
Novartis Venture Fund
VC Fund
3 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $5.1M–$107M
Andrew Keys
Angel
3 United States, India, Norway Seed, Pre-Seed, Series A Software, Finance, Blockchain $1M–$34M
SOSV
VC Fund
3 United States, China, Canada Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software $25k–$5M
FAST — by GETTYLAB
VC Fund
3 United States, United Kingdom, France Pre-Seed, Seed, Series A Software, Artificial Intelligence, Health Care $125k–$40M
SOSV SF & NY (Fka IndieBio)
VC Fund
3 United States, United Kingdom, Canada Seed, Pre-Seed, Convertible Note Biotechnology, Health Care, Medical $50k–$5M
OCCIDENT
VC Fund
2 Switzerland, Germany, Finland Series A, Seed, Series C Health Care, Biotechnology, Medical Device $758k–$401M
SICTIC
VC Fund
2 Switzerland, Germany, Tanzania Seed, Pre-Seed Software, Artificial Intelligence, Information Technology $302k–$3.4M
Founderful
VC Fund
2 Switzerland, United Kingdom, Canada Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $810k–$24M
LASP Capital
VC Fund
2 Brazil, Switzerland, United States Series A, Seed, Pre-Seed Artificial Intelligence, Software, Information Technology $800k–$31M
Amino Collective
VC Fund
2 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $125k–$37M
1kx
VC Fund
2 United States, Germany, Singapore Seed, Series A, Venture - Series Unknown Blockchain, Cryptocurrency, Software $1.8M–$40M
Fongit Seed Invest
VC Fund
2 Switzerland Seed, Series A, Series B Health Care, Medical, Biotechnology $1M–$3.3M
byFounders
VC Fund
2 Denmark, United States, Sweden Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $750k–$65M
Indaco Venture Partners
VC Fund
2 Italy, United Kingdom, Switzerland Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2.3M–$89M
ACE Ventures
VC Fund
2 Switzerland, United States, United Kingdom Seed, Series A, Pre-Seed Information Technology, Artificial Intelligence, Life Science $5M–$18M
VINCI CAPITAL
VC Fund
2 Switzerland, Germany Series A, Series B Medical, Health Care, Biotechnology $8.6M–$36M
Boehringer Ingelheim Venture Fund
VC Fund
2 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Zee Prime Capital
VC Fund
2 United States, United Kingdom, Singapore Seed, Series A Blockchain, Cryptocurrency, Information Technology $2M–$43M
Boost VC
VC Fund
2 United States, Canada, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Software, Virtual Reality, Artificial Intelligence $100k–$8.9M
Mergus Ventures
VC Fund
2 Brazil, United States, Chile Seed, Pre-Seed, Angel Aerospace, AgTech, Biotechnology $200k–$11M
BioMedPartners
VC Fund
2 Switzerland, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $5.3M–$75M
Kickfund
VC Fund
2 Switzerland, France, Germany Seed, Pre-Seed, Convertible Note Health Care, Biotechnology, Manufacturing $110k–$5.7M
Rheingau Founders
VC Fund
2 Germany, United States, Poland Seed, Series A, Pre-Seed Software, E-Commerce, Internet $138k–$14M
NEST pension fund
VC Fund
2 Switzerland Seed, Series A Health Care, Life Science, Biotechnology $1.8M–$3.1M
BlueOcean Ventures
VC Fund
2 Switzerland, India, France Seed, Series A, Series B Health Care, Medical, Personal Health $1M–$20M
Omega Funds
VC Fund
2 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
Lichtsteiner Foundation
VC Fund
2 Switzerland Seed, Series A Biotechnology, Health Care, Medical $1.6M–$6.8M
EFI Lake Geneva Ventures
VC Fund
2 Switzerland, Germany Seed, Series B, Pre-Seed Health Care, Life Science, Biotechnology $2.5M–$16M
Inflection
VC Fund
2 United States, Germany, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Blockchain, Cryptocurrency, Software $500k–$28M
Shine Capital
VC Fund
2 United States, Israel, Spain Seed, Series A, Series B Software, Artificial Intelligence, FinTech $3.6M–$71M
S2S Ventures
VC Fund
2 Switzerland, Germany Pre-Seed, Seed Health Care, Artificial Intelligence, Manufacturing $28k–$3.4M
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A, Venture - Series Unknown Software, Biotechnology, Health Care $680k–$31M
Excellis
VC Fund
2 Switzerland, United Kingdom Seed, Series A, Series B Health Care, Internet of Things, Medical $1.3M–$14M
Sunstone Life Science Ventures
VC Fund
2 Denmark, Sweden, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical $4.1M–$63M
Recipharm Venture Fund
VC Fund
1 Sweden, Switzerland Series A Biotechnology, Medical, Health Care
Privilège Ventures
VC Fund
1 Switzerland, Italy, France Seed, Series A Software, Health Care, Hardware $1.2M–$7M
Polytech Ventures
VC Fund
1 Switzerland, United States, Spain Seed, Series A Financial Services, FinTech, Software $1M–$9.7M
FiveT Capital AG
VC Fund
1 United States, Switzerland Seed, Convertible Note, Initial Coin Offering FinTech, Software, Health Care
Gaingels
VC Fund
1 United States, Canada, United Kingdom Seed, Series A, Series B Software, Health Care, Artificial Intelligence
Access all 280 investors in Switzerland Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Foundation for Innovation and Technology (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 13 investments in Switzerland Life Science startups, 26 in the past 12 months

The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Artificial Intelligence
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France, United States

Investor stats

  • Total investments: 292
  • Round size: Seed $100k–$2.5M; Grant $20k–$125k; Debt Financing $100k–$532k
  • Lead/follow: 94% lead, 6% follow

Portfolio highlights

  • PolaSight — PolaSight delivers a direct, label free visualization of fresh tissue through its automated PolaOne benchtop polarimetric imaging platform. The technology utilizes multi spectral polarimetry to reveal quantitative physical contrast and microstructure details beyond what conventional stained slides show. This non destructive, AI ready optical mapping process provides standardized tissue data right at the bench without requiring freezing or chemical reagents.
  • Swiss Soil — Live biological sensing, adaptive decision-making, and precision inputs that cut waste, respond to real conditions, and build healthier soil.
  • Biodelphis Therapeutics — Swiss biotech developing next-generation protease inhibitors using Antibody-Peptide Inhibitor Conjugates (APIC).
Show all investments...

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 9 investments in Switzerland Life Science startups

Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, Germany, Japan

Investor stats

  • Total investments: 208
  • Round size: Seed $1M–$6M; Series A $2.1M–$13M; Series B $1.7M–$20M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely still investing — raised $150M in 2024

Portfolio highlights

  • Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
  • QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
  • Pearltec AG — Headquartered in Schlieren / Zurich, Pearltec AG develops, produces and delivers solutions for the optimal storage, fixation and positioning of patients. Their products are based on unique, patented technology developed in collaboration with ETH Zurich and renowned university hospitals.They have set theirselves the goal to use the technologycompetence of Pearltec AG for the benefit of humans, animals and industry and to create added value for their customers by excellent quality and convincing application advantages.Pearltec AG is certified according to ISO standard 13485. This certification certifies that their quality management system for the development and manufacture of medical devices meets the highest international standards.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 5 investments in Switzerland Life Science startups, 9 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 308
  • Round size: Seed $1.3M–$12M; Series A $2.1M–$18M; Series B $3.9M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $61M in 2022

Portfolio highlights

  • Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
  • Turn2x — TURN2X decarbonizes the industry by producing Renewable Natural Gas with a unique methanation process.
  • Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Life Science startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, The Netherlands

Investor stats

  • Total investments: 190
  • Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $282M in 2023

Portfolio highlights

  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Vaderis Therapeutics — Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.
Show all investments...

Lakestar
VC Fund · Zürich, Zurich, Switzerland · 4 investments in Switzerland Life Science startups, 26 in the past 12 months

Lakestar invests in founders and technologies shaping Europe's future, helping build resilience, sovereignty, and long-term growth in a changing world.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 258
  • Round size: Seed $2.2M–$19M; Series A $6.7M–$65M; Series B $17M–$91M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely actively investing — fresh fund, raised $300M in 2026

Portfolio highlights

  • Ravical — Ravical equips professional services firms with AI agents that collaborate and scale, unlocking practical value today and future growth tomorrow.
  • Modulate — Modulate uses revolutionary machine learning to proactively detect and escalate toxic behavior in your game. ToxMod becomes an expert in your code of conduct and empowers your moderators to make the right decisions to protect your community from the worst behavior happening in voice chat in real time.
  • Ares Intelligence — Ares Intelligence conducts automated internal interviews across a company's workforce to analyze operational inefficiencies and identify where the business can integrate artificial intelligence effectively.
Show all investments...

Eclosion SA
VC Fund · Geneva, Geneve, Switzerland · 4 investments in Switzerland Life Science startups

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up can reasonably attract risk capital. Eclosion helps you to cross the bridge to convert your innovation into a realistic venture and to enter into its growth phase.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series C
  • Geography: Switzerland

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$3.3M; Series C $20M–$28M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
  • Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
  • MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in Switzerland Life Science startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 190
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Mueon — semiconductor-based systems for AI and hyperscale computing
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 4 investments in Switzerland Life Science startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 339
  • Round size: Series A $4.7M–$68M; Series B $10M–$105M; Series C $12M–$107M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $5M in 2024

Portfolio highlights

  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Show all investments...

White Loop Capital
VC Fund · Lyon, Rhone-Alpes, France · 3 investments in Switzerland Life Science startups

White Loop Capital is the first investment firm specialized in crypto-assets in France. Accompanying those who dare.

Show more...

Investment focus

  • Industry: Software, Blockchain, Cryptocurrency
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, Canada, Switzerland

Investor stats

  • Total investments: 22
  • Round size: Seed $1M–$1M; Pre-Seed $1.2M–$1.2M; Series A $10M–$27M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • ether.fi — EtherFi is a non-custodial decentralized ETH staking method that distributes staking to node operators in exchange for rewards.
  • Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
  • LayerZero Labs — An omnichain interoperability protocol. LayerZero enables the realization of cross-chain applications with a low level communication primitive.
Show all investments...

Kinled Holding
VC Fund · New York, New York, United States · 3 investments in Switzerland Life Science startups

Kinled was founded in 1980 to retain the investment assets of the Aisher family. In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists. Since then, Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 144
  • Round size: Seed $594k–$14M; Series A $1.7M–$40M; Venture - Series Unknown $1.6M–$13M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
  • Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
  • TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pfizer Venture Investments
VC Fund · New York, New York, United States · 3 investments in Switzerland Life Science startups

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of its industry.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Series A $12M–$100M; Series B $20M–$120M; Series C $15M–$102M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $600M in 2018

Portfolio highlights

  • Flare Therapeutics — Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets fortranscription factor regulation to address mutations that cause disease. Its drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
  • Flexion Therapeutics — Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Switzerland Life Science startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 247
  • Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Rein Therapeutics — Harnessing fibrosis, unleashing life
Show all investments...

Andrew Keys
Angel · 3 investments in Switzerland Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Software, Finance, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Norway

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 3 investments in Switzerland Life Science startups

SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 3821
  • Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $306M in 2023

Portfolio highlights

  • Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
  • Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
  • Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Show all investments...

FAST — by GETTYLAB
VC Fund · San Francisco, California, United States · 3 investments in Switzerland Life Science startups

Backing engineers building awe, wonder, speed.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 109
  • Round size: Seed $500k–$7.6M; Pre-Seed $125k–$2.3M; Series A $5.5M–$40M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Modelwise — Automated functional safety analysis via drag & drop. Seamless Integration. Faster Analyses. Zero Defects. More Savings.
  • Fluent Metal — Fluent Metal is a company that makes metal 3D printing economical, efficient, and safe.
  • Integrated Reasoning — Integrated Reasoning builds computer hardware to efficiently solve optimization problems. We're making it faster and cheaper to solve problems like scheduling airline pilots or packing boxes into trucks.
Show all investments...

SOSV SF & NY (Fka IndieBio)
VC Fund · San Francisco, California, United States · 3 investments in Switzerland Life Science startups

IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 676
  • Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
  • Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
  • Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Show all investments...

OCCIDENT
VC Fund · Zug, Zug, Switzerland · 2 investments in Switzerland Life Science startups

OCCIDENT invests in deep tech start-ups with a focus on spin-offs originating from scientific research, thus having a real impact and enabling concrete solutions for different challenges facing society today. As an owner-managed venture capital investor with offices in Munich and Zug, OCCIDENT supports start-ups in the life sciences and industrial tech sectors from the seed stage onwards, accompanies their portolio companies over the long term both financially as well as with their extensive experience, and thus enables founding teams to achieve outstanding results. With a strong entrepreneurial mindset, OCCIDENT invests its own money and makes decisions based on sustainable potential for success. Co-operation with the founding teams of their portfolio companies motivates the OCCIDEN team and inspires them every day. They are energized by their passion and drive, and the often very intense exchange spurs them on to tackle challenges together. OCCIDENT’s aim with each and every one of their investments is to make a positve contribution to society in a sustainable way.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series C
  • Geography: Switzerland, Germany, Finland

Investor stats

  • Total investments: 41
  • Round size: Seed $758k–$4.6M; Series A $2.2M–$12M; Series C $8.3M–$401M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

SICTIC
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Switzerland Life Science startups

SICTIC is the leading angel investor network in Switzerland with the largest Swiss seed-stage startup dealflow.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Switzerland, Germany, Tanzania

Investor stats

  • Total investments: 289
  • Round size: Seed $537k–$3.4M; Pre-Seed $302k–$2.7M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Agrinorm — Agrinorm is a Swiss deep tech company leveraging cutting edge machine learning techniques for the optimization of fruits and veg supply chains.
  • hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
  • Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
Show all investments...

Founderful
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Switzerland Life Science startups, 10 in the past 12 months

Founderful is Switzerland’s leading pre-seed fund. Founderful is the first, fast, and founder-friendly, backing Switzerland's best tech entrepreneurs to become global market leaders. Founded in 2019 and is located in Zurich, Zurich.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, United Kingdom, Canada

Investor stats

  • Total investments: 112
  • Round size: Seed $1.5M–$14M; Pre-Seed $810k–$4.3M; Series A $3M–$24M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — raised $143M in 2024

Portfolio highlights

  • UniSieve — UniSieve is a cleantech company that provides molecular separation membrane solutions for a wide range of applications. Its platform technology enables a unique combination of various molecular sieves and polymeric membranes, yielding reliable separation solutions. The company was founded in 2018 and is headquartered in Zurich, Switzerland.
  • Fusionality — Fusionality is a Swiss fusion-technology company focused on measurement, control, and data systems for fusion devices.They combine expertise in fusion physics, control engineering, AI/ML, simulation, diagnostics, and real-time software.Their goal is to help fusion companies and research labs operate devices more efficiently and accelerate thedevelopment of commercial fusion energy.
  • Exclaim Robotics — Autonomous mobile robots for the AI data center.
Show all investments...

LASP Capital
VC Fund · Brasil, Sao Paulo, Brazil · 2 investments in Switzerland Life Science startups

LASP Capital is a investment firm focuses on global growth companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Brazil, Switzerland, United States

Investor stats

  • Total investments: 30
  • Round size: Seed $800k–$6M; Pre-Seed $2.4M–$5.3M; Series A $6.5M–$31M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kaya Pay — Track owner-furnished materials from procurement through delivery, installation, and turnover.
  • Nuvia — Nuvia is an artificial Intelligence automation platform that helps with sales process, lead generation and hyper-personalized conversions
  • Neofin — AI-powered software for B2B payments workflows that automates and streamlines financial processes, transforming the way companies get paid and pay their bills
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Amino Collective
VC Fund · Berlin, Berlin, Germany · 2 investments in Switzerland Life Science startups, 7 in the past 12 months

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 47
  • Round size: Seed $2.4M–$14M; Pre-Seed $125k–$10M; Series A $12M–$37M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
  • Frontier Computing — Frontier Computing is a biocomputing company growing large-scale neuronal tissue, living hardware with memory baked in at the cellular level.
  • Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Show all investments...

1kx
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Switzerland Life Science startups, 8 in the past 12 months

1kx is a research-driven global investment firm making trust instant, open, and programmable, with 160+ investments since 2018 across DeFi, stablecoins, and onchain infrastructure.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, Germany, Singapore

Investor stats

  • Total investments: 184
  • Round size: Seed $1.8M–$11M; Series A $5M–$28M; Venture - Series Unknown $3M–$40M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Predicate — Define transaction rules to secure financial products.
  • KOR Protocol — KOR Protocol is a decentralized intellectual property (IP) infrastructure designed to empower creators, protect rights, and enable seamless collaboration and monetization of IP assets across various industries, including music, film, TV, gaming, and art. Backed by notable entities like Animoca Brands, Republic, Niantic, Sfermion, Solana, andprominent creators such as Black Mirror, Disclosure, deadmau5, and Richie Hawtin, KOR leverages blockchain, AI, and DeFi to offer a transparent, efficient, and scalable environment for IP expansion.
  • Freehand — Freehand AI Teams resolve disputes, negotiate credits, and settle enterprise spend autonomously; recover 2-5% margins with 100% audit coverage.
Show all investments...

Fongit Seed Invest
VC Fund · Plan-les-ouates, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland

Investor stats

  • Total investments: 9
  • Round size: Seed $1M–$1.4M; Series A $2.3M–$3.3M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • EBAMed — EBAMed builds CardioKit: live ultrasound that follows the heart during radiotherapy and gates the beam, whether the heart is the target or the organ to protect.
  • Gmelius — Gmelius is the world's first 360 email collaboration platform designed for Gmail and your company's daily apps. Join the async movement!
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

byFounders
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Switzerland Life Science startups, 16 in the past 12 months

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Denmark, United States, Sweden

Investor stats

  • Total investments: 135
  • Round size: Seed $1.5M–$9.4M; Pre-Seed $750k–$4.3M; Series A $6.1M–$65M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2021

Portfolio highlights

  • Fluencify — Fluencify is an innovative creator marketing platform that runs end to end user generated content programs for global brands. The software powered solution enforces brand quality guidelines, handles global creator payments, and provides contracted view guarantees to turn influencer marketing into a scalable utility framework.
  • Verda — Verda provides a full-stack AI cloud platform for the development, training, and deployment of AI models. Its services include GPU instances, instant clusters, serverless containers, managed storage, and other cloud infrastructure powered by NVIDIA hardware. Verda also operates an AI Lab focused on large-scale training, inference optimization, reinforcement learning, and AI systems engineering. Its platform serves AI developers and organizations across the full AI lifecycle, from prototyping to scalable inference.
  • Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 2 investments in Switzerland Life Science startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Italy, United Kingdom, Switzerland

Investor stats

  • Total investments: 50
  • Round size: Series A $3.5M–$33M; Series B $8.9M–$89M; Venture - Series Unknown $2.3M–$21M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $302M in 2018

Portfolio highlights

  • Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

ACE Ventures
VC Fund · London, England, United Kingdom · 2 investments in Switzerland Life Science startups

ACE Ventures is a Swiss-based, early-stage VC firm partnering with the next generation of Swiss tech founders who are building transformative businesses, both in Switzerland and abroad.

Show more...

Investment focus

  • Industry: Information Technology, Artificial Intelligence, Life Science
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Switzerland, United States, United Kingdom

Investor stats

  • Total investments: 7
  • Round size: Seed $5M–$8M; Series A $6M–$18M
  • Lead/follow: 71% lead, 29% follow

Portfolio highlights

  • Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
  • Scholé — AI-native personalized learning
  • Adaptyv Biosystems — Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
Show all investments...

VINCI CAPITAL
VC Fund · Lausanne, Vaud, Switzerland · 2 investments in Switzerland Life Science startups

Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts. Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operational background in growth, turn-around, consolidation, IPOs and M&A situations.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 15
  • Round size: Series A $8.6M–$20M; Series B $21M–$36M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2012

Portfolio highlights

  • Anergis — Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne inSwitzerland.
  • SENSIMED — Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best beused in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
  • beqom — beqom is a Total Compensation Management Software Solution focused exclusively on managing compensation & performance for HR & Sales.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 2 investments in Switzerland Life Science startups, 6 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

Zee Prime Capital
VC Fund · Bratislava, Bratislava, Slovakia (Slovak Republic) · 2 investments in Switzerland Life Science startups

Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$9M; Series A $5M–$43M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • TrueDAO — TrueDAO is a new-generation AI-native decentralized autonomous financial infrastructure. Built on the underlying logic of DAO community co-governance, it leverages smart contracts to construct an on-chain financial system integrating AI algorithm scheduling, staking, and dynamic protection. It optimizes economic parameters and asset strategies inreal time via AI models, delivers low-volatility and sustainable value growth paths for digital assets, and pioneers an innovative paradigm of autonomous finance.
  • Share — From subsea cables to last-mile networks, Share coordinates fragmented infrastructure into a single ecosystem.
  • Neuron Industries — Neuron Industries develops AI-native industrial controllers to replace traditional PLCs, enabling deterministic factory automation via plain English. Neuron Industries was founded in 2026 by Dennis Ren and Kenneth Rhee.
Show all investments...

Boost VC
VC Fund · San Mateo, California, United States · 2 investments in Switzerland Life Science startups, 14 in the past 12 months

Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.

Show more...

Investment focus

  • Industry: Software, Virtual Reality, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 448
  • Round size: Seed $195k–$6M; Pre-Seed $100k–$2.6M; Venture - Series Unknown $620k–$8.9M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $88M in 2025

Portfolio highlights

  • SkinBit — SkinBit is a healthtech company that develops AI-powered skin cancer detection, digital mapping, and health monitoring solutions.
  • heXem bio — heXem bio specializes in recording solutions for the early development of humans for longevity.
  • Elita — Store your dog's stem cells with Elita. One-time opportunity to protect their future health and avoid costly surgeries later in life.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Mergus Ventures
VC Fund · Nova Lima, Minas Gerais, Brazil · 2 investments in Switzerland Life Science startups

Investing in unconventional founders solving challenges with cutting-edge, future-forward technologies.

Show more...

Investment focus

  • Industry: Aerospace, AgTech, Biotechnology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Brazil, United States, Chile

Investor stats

  • Total investments: 28
  • Round size: Seed $800k–$11M; Pre-Seed $200k–$500k
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Spaceium — Spaceium develops a spacecraft docking system to support interplanetary missions. Its docking mechanism aims to offer solutions in the fields of In-space refueling with sustainable fueling stations can be an essential part of space exploration. The company's service hubs efficiently store and transfer cryogenic (extremely cold) andnon-cryogenic fuels with zero loss during storage and transfer.
  • Starcloud — Explore Starcloud's pioneering data centers in space, offering 90% lower electricity costs and 24/7 solar-powered efficiency. Join us today & learn more!
  • Starcloud — Lumen Orbit provides in-orbit cloud computing and data relay for satellites.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in Switzerland Life Science startups

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 88
  • Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $106M in 2018

Portfolio highlights

  • T-CURX — T-CURX is a biotechnology company focused on the development of personalized cancer immunotherapies. Utilizing a proprietary platform, T-CURX aims to advance the field of T cell therapies to address the challenges faced in treating various cancers. The company's innovative approach involves the creation of a new generation of T cells designedto improve patient outcomes. As a spin-out from the University Clinics Würzburg, Germany, T-CURX leverages the expertise of its co-founders, including Prof. Michael Hudecek, to pioneer in the area of CAR-T cell-based medicines. With a commitment to transforming cancer treatment, T-CURX is at the forefront of developing targeted therapies that offer hope for a more effective and personalized approach to cancer care.
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Kickfund
VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in Switzerland Life Science startups, 11 in the past 12 months

Kickfund is a Venture Capital fund that systematically backs companies that successfully complete Venture Kick.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Switzerland, France, Germany

Investor stats

  • Total investments: 51
  • Round size: Seed $1.1M–$5.7M; Pre-Seed $335k–$4M; Convertible Note $110k–$118k
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $80M in 2023

Portfolio highlights

  • Bewelab SA — Bewe is a mobile game designed to reduce cravings, using neuroscience to automatically retrain your brain and effortlessly reclaim your health.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • Helix Robotics — We are building the first commercial soft manipulator
Show all investments...

Rheingau Founders
VC Fund · Berlin, Berlin, Germany · 2 investments in Switzerland Life Science startups

Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains. Besides the financial investment, we offer strategic support through the mentorship of our partners.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Poland

Investor stats

  • Total investments: 90
  • Round size: Seed $138k–$6.3M; Pre-Seed $770k–$2.7M; Series A $2.7M–$14M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
  • Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
  • Akhetonics — Akhetonics is a photonic computing company building all-optical processors for ultra-fast AI and high-performance computing. It is a deep-tech semiconductor company focused on photonic (light-based) computing hardware. It develops all-optical processors designed to accelerate AI, reasoning, and complex computational workloads. The company aims todeliver ultra-fast, energy-efficient computing beyond traditional electronic chips.
Show all investments...

NEST pension fund
VC Fund · 2 investments in Switzerland Life Science startups

For more than 35 years, Nest, as the first ecological and ethical pension fund in Switzerland, has remained true to its guiding principle: the optimal provision for the companies affiliated with us and their employees.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 3
  • Round size: Seed $1.8M–$3.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
  • Comphya — Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
  • Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
Show all investments...

BlueOcean Ventures
VC Fund · Plan-les-ouates, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland. BlueOcean Ventures is based in Geneva, Switzerland.

Show more...

Investment focus

  • Industry: Health Care, Medical, Personal Health
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, India, France

Investor stats

  • Total investments: 18
  • Round size: Seed $1M–$3.1M; Series A $2.3M–$20M; Series B $4M–$16M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • UGX.ai — Connect, process, and optimise industrial operations across manufacturing, OEM, and clean energy with UGX.AI.
  • RockFlow — RockFlow is an investment wonderland for the young. Born to be brave, invest in the moment.
  • official.fm — Officials.fm has done an incredible job at creating a community that brings together different artists and listeners in a very creative and dynamic way.
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 2 investments in Switzerland Life Science startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 172
  • Round size: Series A $16M–$200M; Series B $38M–$165M; Series C $14M–$208M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $470M in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
Show all investments...

Lichtsteiner Foundation
VC Fund · Berne, Bern, Switzerland · 2 investments in Switzerland Life Science startups

Boosting health pioneers. We invest in early stage start-ups in different sectors: medtech, life science, biotech, mental health, public health, well-being.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $1.6M–$6.8M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Hemostod — Developing universal platelets and next-generation diagnostics
  • DigeHealth — DigeHealth is a Swiss company building a wearable that continuously listens to your gut, turning bowel sounds and body signals into a daily picture of your gut health.
  • Allegria Therapeutics — Allegria Therapeutics is a Swiss biotech company targeting mast cells to redefine the treatment of allergic and inflammatory diseases.
Show all investments...

EFI Lake Geneva Ventures
VC Fund · Geneva, Geneve, Switzerland · 2 investments in Switzerland Life Science startups

EFI Lake Geneva Ventures is a seed and early-stage investment strategy based in Geneva, Switzerland. Founded in 2020, our mission is to foster innovation by investing at an early stage in fast-growing innovative Swiss companies in Technology, Life Sciences and Medtech.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Biotechnology
  • Stage:Seed, Series B, Pre-Seed
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 7
  • Round size: Seed $2.5M–$3.8M; Series B $5.1M–$16M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Hemotune — hemotune develops a revolutionary medical device for blood purification to provide the means to treat critically ill patients and save lives.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

Inflection
VC Fund · Boston, Massachusetts, United States · 2 investments in Switzerland Life Science startups

Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Software
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $2M–$13M; Pre-Seed $500k–$11M; Venture - Series Unknown $5.4M–$28M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — raised $40M in 2022

Portfolio highlights

  • Ubitium — Ubiquitous computing, universal RISC-V microprocessor
  • Foundational — Foundational is a startup focused on satellite laser ranging (SLR) automation.
  • Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Shine Capital
VC Fund · New York, New York, United States · 2 investments in Switzerland Life Science startups, 16 in the past 12 months

Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to create iconic businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Spain

Investor stats

  • Total investments: 82
  • Round size: Seed $3.6M–$21M; Series A $12M–$25M; Series B $10M–$71M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely actively investing — fresh fund, raised $1M in 2026

Portfolio highlights

  • MEANT 2B — MeantToBe is an AI-powered matchmaking platform designed to move beyond swipe-based dating apps by using personalized recommendations and behavioral signals to suggest more compatible romantic and social connections. It leverages machine learning to understand user preferences over time, aiming to improve match quality, reduce swipe fatigue, andcreate more meaningful interactions between users in a modern, AI-driven social discovery experience. Focused on next-generation relationship discovery.
  • Pilgrim — Pioneering a biologically enhanced future for humanity.
  • SafeWorld — SafeWorld is a safety testing platform for companies deploying robots around people, helping them assess and improve the safety.
Show all investments...

S2S Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Switzerland Life Science startups

S2S Ventures is a fully student-led VC fund from Switzerland, backed by some of the country's most successful entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Manufacturing
  • Stage:Pre-Seed, Seed
  • Geography: Switzerland, Germany

Investor stats

  • Total investments: 28
  • Round size: Seed $954k–$3.4M; Pre-Seed $28k–$2.7M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $11M in 2021

Portfolio highlights

  • Haicker — Continuous, automated vulnerability scanning for your web codebases. Cheaper, faster, and more efficient than traditional pentesters.
  • Scanvio — Scanvio Medical provides gynecologists, endometriosis centers and ultrasound manufacturers with an AI-guided ultrasound software for faster endometriosis diagnosis.
  • Forgis — Forgis is leading the next industrial revolution by introducing industrial intelligence into factories, which boosts the competitiveness of Western manufacturing.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Switzerland Life Science startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 851
  • Round size: Seed $680k–$6.5M; Series A $3M–$31M; Venture - Series Unknown $911k–$12M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
  • Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
Show all investments...

Excellis
VC Fund · Turin, Piemonte, Italy · 2 investments in Switzerland Life Science startups

Early-stage deep tech VC backing Italian researcher-founders building frontier technologies at the world's top institutions.

Show more...

Investment focus

  • Industry: Health Care, Internet of Things, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Switzerland, United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $1.3M–$10M; Series A $5.8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MintNeuro — MintNeuro is pioneering the use of semiconductor technology in next-generation neural implants.
  • Helix Robotics — We are building the first commercial soft manipulator
  • Annaida Technologies — Empowering fertility providers and researchers with AI-driven metabolomic platforms. Non-invasive, real-time insights at the microscale for personalized medical treatments.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 2 investments in Switzerland Life Science startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 63
  • Round size: Series A $5.5M–$61M; Series B $9.5M–$58M; Series C $4.1M–$63M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2019

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Recipharm Venture Fund
VC Fund · 1 investments in Switzerland Life Science startups

Recipharm Venture Fund is part of Recipharm AB.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A
  • Geography: Sweden, Switzerland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
  • Cinclus Pharma — A Swedish pharma company bringing relief to the world with the clinical stage drug candidate linaprazan glurate for gastric acid related diseases.
Show all investments...

Privilège Ventures
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Switzerland Life Science startups

Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary over five decades of combined investment experience Where Entrepreneurs Thrive Rooted in reality, reaching for the extraordinary Authentic, dedicated, disciplined, and goal-oriented, our team drives meaningful and lasting success About Team

Show more...

Investment focus

  • Industry: Software, Health Care, Hardware
  • Stage:Seed, Series A
  • Geography: Switzerland, Italy, France

Investor stats

  • Total investments: 18
  • Round size: Seed $1.2M–$5.3M; Series A $4.1M–$7M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Xsensio — Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
  • ENANTIOS — ENANTIOS specializes in creating benchtop analytical instruments that provide industries, research institutions, and academic facilities.
  • Hydromea — Hydromea is a Swiss company with core expertise in underwater robotics, through-water wireless communication networks and underwater navigation.
Show all investments...

Polytech Ventures
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Switzerland Life Science startups

Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Seed, Series A
  • Geography: Switzerland, United States, Spain

Investor stats

  • Total investments: 50
  • Round size: Seed $1M–$5M; Series A $2.3M–$9.7M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2016

Portfolio highlights

  • Relai — All you need to get started is to download our award winning Relai app, complete a simple verification and start buying with as little as 50 CHF/EUR.
  • Hemostod — Developing universal platelets and next-generation diagnostics
  • Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Show all investments...

FiveT Capital AG
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Switzerland Life Science startups

FiveT is an independent alternative asset manager established in 2006. Starting in 2021, FiveT set out to finance the foundation of the hydrogen economy.

Show more...

Investment focus

  • Industry: FinTech, Software, Health Care
  • Stage:Seed, Convertible Note, Initial Coin Offering
  • Geography: United States, Switzerland

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ZELF — Zelf is a neobank targeting Gen Z to bring financial services to where they live – in messengers. This is the lightest bank with the easiest onboarding process taking up to 60 sec to issue a card, receive and send money without leaving the messenger. We are uniquely offering AI-powered voice control over the most of financial operations, whichmakes us first voice-enabled banking for Gen Z who prefers voice interactions with their devices.
  • LimeWire — We are under maintenance.
  • PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 1 investments in Switzerland Life Science startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 629
  • Lead/follow: no public data

Portfolio highlights

  • Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
  • Paxton — Regulatory Intelligence, with the speed of Generative AI.
  • Viridian Space — Viridian Space develops a propulsion technology intended to use oxygen to stay in ultra-low earth orbit. The company was founded in 2021 and is based in Culver City, California.
Show all investments...

Life Science Investor funding in Switzerland at a glance

Stats across 229 deals from 280 investors.

280
investors
in Switzerland Life Science startups
229
deals
in Switzerland Life Science startups
$928k
median round
in Switzerland Life Science startups
41%
lead investors
lead at least one round
35%
Grant
most common funding stage
89/11
VC / Angel
share of investor count

Access all 280 investors in Switzerland Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 280 investors investing in Switzerland Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists